Latest Shareholder Approvals News

US1 Critical Minerals has provided clarity on the issuance of 50 million fee options to consultants related to its December 2025 placement, reaffirming shareholder approval is pending and no funds will be raised from this issuance.

Enova Mining has successfully raised $2 million through a heavily oversubscribed share placement, enabling accelerated drilling and test work at its East Salinas and Charley Creek projects. This capital injection positions the company to advance its critical minerals exploration amid growing demand for rare earth elements.

Peel Mining has agreed to sell its South Cobar Copper Project to Aeris Resources in a $214 million transaction, while spinning off its remaining assets into a new ASX-listed company, NewCo. The deal offers Peel shareholders immediate value and ongoing exposure to a diversified metals portfolio.

Strategic Energy Resources Limited is set to consolidate its shares on a 1-for-20 basis, significantly reducing the number of shares on issue and adjusting option exercise prices. The move, effective from April 1, 2026, follows all necessary approvals and aims to streamline the company’s capital structure.

Dundas Minerals has raised $2.5 million through a strongly supported share placement to fund gold exploration drilling at its Kalgoorlie and expanded Romano projects in Western Australia.

OncoSil Medical’s CEO Nigel Lange has agreed to a 10% salary reduction, opting instead to receive shares at a significant premium, reinforcing executive commitment to shareholder value and cost discipline.

Matsa Resources launches a major drilling campaign at Fortitude North targeting up to 1.85 million ounces of gold, supported by a $17.5 million loan facility from major shareholder Deutsche Balaton.

Tamboran Resources Corporation reported a 26% reduction in half-year losses as it progresses key natural gas projects in Australia’s Beetaloo Basin and prepares for a major acquisition of Falcon Oil & Gas Ltd.

Critical Resources Limited has successfully completed the first tranche of its capital raising, securing $1.605 million through a substantial share and option issuance. The company now awaits shareholder approval for the second tranche, which involves director participation.

Empire Resources has successfully raised A$5 million through a two-tranche placement to accelerate exploration at its Yuinmery and Penny’s projects, with strong backing from existing and new investors.

Neuren Pharmaceuticals has initiated a discretionary on-market share buy-back program of up to 5%, citing a strong cash position and undervaluation relative to internal and analyst assessments.

HighCom Limited has announced a $7 million capital raise alongside a $1 million Share Purchase Plan to support working capital and product innovation, aiming for a strong revenue rebound and profitability in the second half of FY26.